Semmax Financial Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.29K | Hold |
79
| – | – | ﹤0.01% | 318 |
|
2025
Q1 | $2.55K | Hold |
79
| – | – | ﹤0.01% | 313 |
|
2024
Q4 | $2.4K | Hold |
79
| – | – | ﹤0.01% | 287 |
|
2024
Q3 | $2.98K | Hold |
79
| – | – | ﹤0.01% | 274 |
|
2024
Q2 | $3.71K | Hold |
79
| – | – | ﹤0.01% | 299 |
|
2024
Q1 | $3.07K | Sell |
79
-3
| -4% | -$116 | ﹤0.01% | 274 |
|
2023
Q4 | $3.97K | Hold |
82
| – | – | ﹤0.01% | 267 |
|
2023
Q3 | $3.84K | Buy |
+82
| New | +$3.84K | ﹤0.01% | 244 |
|
2022
Q4 | $3K | Hold |
84
| – | – | ﹤0.01% | 219 |
|
2022
Q3 | $4K | Sell |
84
-2,243
| -96% | -$107K | ﹤0.01% | 198 |
|
2022
Q2 | $107K | Sell |
2,327
-247
| -10% | -$11.4K | 0.04% | 98 |
|
2022
Q1 | $95K | Sell |
2,574
-201
| -7% | -$7.42K | 0.04% | 113 |
|
2021
Q4 | $84K | Sell |
2,775
-656
| -19% | -$19.9K | 0.03% | 116 |
|
2021
Q3 | $115K | Sell |
3,431
-355
| -9% | -$11.9K | 0.04% | 109 |
|
2021
Q2 | $151K | Sell |
3,786
-242
| -6% | -$9.65K | 0.05% | 109 |
|
2021
Q1 | $181K | Buy |
4,028
+3,989
| +10,228% | +$179K | 0.06% | 104 |
|
2020
Q4 | $2K | Hold |
39
| – | – | ﹤0.01% | 210 |
|
2020
Q3 | $2K | Hold |
39
| – | – | ﹤0.01% | 209 |
|
2020
Q2 | $2K | Hold |
39
| – | – | ﹤0.01% | 227 |
|
2020
Q1 | $2K | Hold |
39
| – | – | ﹤0.01% | 222 |
|
2019
Q4 | $2K | Hold |
39
| – | – | ﹤0.01% | 255 |
|
2019
Q3 | $2K | Hold |
39
| – | – | ﹤0.01% | 246 |
|
2019
Q2 | $3K | Hold |
39
| – | – | ﹤0.01% | 255 |
|
2019
Q1 | $3K | Hold |
39
| – | – | ﹤0.01% | 389 |
|
2018
Q4 | $2K | Buy |
+39
| New | +$2K | ﹤0.01% | 394 |
|